Microdistributions of prospective BNCT-compound CuTCPH in tissue sections with a heavy ion microbeam

P Stoliar1, A J Kreiner, M E Debray

  • 1Departamento de Física, Argentine Atomic Energy Commission, CNEA, Av. Gral. Paz 1499, CP 1650, Bienos Aires, Villa Martelli, Argentina.

Insights

Researchers mapped the distribution of the boron compound CuTCPH in hamsters using micro-PIXE. They found highly non-uniform copper concentrations in various organs and tumor tissues, crucial for Boron Neutron Capture Therapy (BNCT) development.

Area of Science:

  • Nuclear Physics
  • Materials Science
  • Biomedical Engineering

Background:

  • Boron Neutron Capture Therapy (BNCT) is an experimental cancer treatment.
  • Carborane-containing porphyrins are promising compounds for BNCT.
  • Understanding the microdistribution of these compounds is crucial for treatment efficacy.

Purpose of the Study:

  • To investigate the microdistributions of the prospective BNCT compound CuTCPH.
  • To analyze elemental concentrations in different organs of tumor-bearing and normal Syrian hamsters.

Main Methods:

  • Utilized micro-PIXE (Particle Induced X-ray Emission) with a focused 16O ion beam.
  • Employed a heavy-ion scanning magnetic quadrupole triplet microprobe for high-resolution X-ray spectroscopy.
  • Analyzed cryo-sectioned and freeze-dried tissue samples from Syrian hamsters with induced Squamous Cell Carcinomas.

Main Results:

  • Obtained two-dimensional elemental concentration maps by scanning the microbeam over tissue sections.
  • Revealed very non-uniform copper (Cu) concentrations in all analyzed tissue sections.
  • Demonstrated significant variations in Cu distribution within different organs and tumor tissues.

Conclusions:

  • The microdistribution of CuTCPH is highly heterogeneous in both normal and tumor tissues.
  • These findings highlight the importance of microdistribution analysis for optimizing BNCT compound delivery.
  • Further research is needed to understand factors influencing CuTCPH accumulation and distribution for improved therapeutic outcomes.

Related Concept Videos